Evaluating the role of Emergency Departments in managing fatty liver disease
Pre- Emergency / Acceptance Departments Study, Prevention in Emergency / Acceptance Departments: the Case of Hepatic Steatosis
This study is trying to see how Emergency Departments can help find and manage fatty liver disease in patients who come in for care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20189 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of L'Aquila Academic / other |
| Locations | 1 site (L'Aquila, Italy/L'Aquila) |
| Trial ID | NCT05436860 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess how Emergency Departments can enhance the prevention and management of chronic inflammatory diseases, specifically focusing on hepatic steatosis. By determining the prevalence of fatty liver disease among patients admitted to the Emergency Department, the study seeks to inform future pilot studies that will explore the effectiveness of Emergency Departments as a preventive health tool. The methodology includes conducting liver ultrasounds on eligible patients to gather data on the condition's prevalence.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 who are admitted to the Emergency Department with a white or green code.
Not a fit: Patients under 18 or those admitted with a yellow or red code may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved screening and management strategies for patients with fatty liver disease.
How similar studies have performed: While this approach is novel in the context of Emergency Departments, similar studies have shown promise in other settings for chronic disease management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 18 * Patients admitted to Emergency department in white or green code Exclusion Criteria: * Patients under 18 * Patients admitted to Emergency department in yellow or red code
Where this trial is running
L'Aquila, Italy/L'Aquila
- Clara Balsano — L'Aquila, Italy/L'Aquila, Italy (Recruiting)
Study contacts
- Study coordinator: Clara Balsano, MD
- Email: clara.balsano@univaq.it
- Phone: +39 0862434774
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.